Technology News and Research

RSS

Genzyme and Isis Pharmaceuticals: Phase 3 mipomersen study in heFH patients meets primary endpoint

Genzyme Corp. and Isis Pharmaceuticals Inc. today announced that the phase 3 study of mipomersen in patients with heterozygous familial hypercholesterolemia (heFH) met its primary endpoint with a highly statistically significant 28 percent reduction in LDL-cholesterol after 26 weeks of treatment, compared with an increase of 5 percent for placebo.

10 Feb 2010

Practice Fusion patient survey: Doctors are making use of EHR systems

The health IT landscape has changed fundamentally in the first year since the American Recovery and Reinvestment Act was signed into law. American patients are seeing their doctors make the switch to Electronic Health Record (EHR) systems, according to a survey conducted by GfK Roper for Practice Fusion, the fastest growing EHR community in the US.

10 Feb 2010

STDUniversity.org launches interactive, personalized STD test recommendation

STDUniversity.org is the first website to provide an interactive, personalized STD test recommendation developed by academic and medical experts. This expert-based tool incorporates screening guidelines from the Centers for Disease Control and Prevention (CDC), U.S. Agency for Healthcare Research and Quality (AHRQ), and the U.S. Preventive Service Task Force (USPSTF).

10 Feb 2010

IndicatorEDG survey reveals Americans find less chance of achieving personal dreams

Luth Research's IndicatorEDG survey finds Americans are less likely to feel their dreams are attainable. Back in the third quarter of 2006, 62% of Americans said they had an excellent, very good or good chance of achieving their personal dreams.

10 Feb 2010

Alexza Pharmaceuticals announces development and commercialization collaboration with Biovail Laboratories International

Alexza Pharmaceuticals, Inc. announced today that it has established a collaboration with Biovail Laboratories International SRL, a subsidiary of Biovail Corporation, to develop and commercialize AZ-004 (Staccato® loxapine) in the U.S. and Canada. AZ-004 is Alexza's lead program, based on the company's proprietary technology, the Staccato system. Alexza submitted its New Drug Application (NDA) for Staccato loxapine in December 2009. Alexza is seeking regulatory approval to market AZ-004, an inhalation product candidate developed for the rapid treatment of agitation in patients with schizophrenia or bipolar disorder.

10 Feb 2010

Kinexus Bioinformatics announces the commercial release of Protein Kinase Microarray

Kinexus Bioinformatics Corporation announced the commercial release of its novel Protein Kinase Microarray with 200 recombinant human protein kinases for screening. The microarray has wide utility including applications for drug target counter screening, to identify novel kinase substrates, establish kinase antibody specificities, and for the discovery and testing of protein kinase-protein and protein kinase-compound interactions.

10 Feb 2010

Second-quarter fiscal 2010 results announced by Bioniche Life Sciences

Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, today announced financial results for its Fiscal 2010 second quarter, ended December 31, 2009.

10 Feb 2010

Bombarding DNA nucleotides and mammalian meat with ‘femto-neutrons’ open new path to femtomedicine

Bombarding DNA nucleotides and mammalian meat with ‘femto-neutrons’ has opened up the path to femtomedicine, an entirely new cancer diagnostics, it was reported today at First Global Congress on NanoEngineering for Medicine and Biology in Houston, TX.

10 Feb 2010

MEDecision completes latest round of interoperability tests with other leading EHR vendors

MEDecision, Inc., a leading provider of collaborative healthcare management solutions, today announced the successful completion of its latest round of interoperability tests with other leading electronic health record (EHR) vendors at the 11th Annual Integrating the Healthcare Enterprise (IHE) North America Connectathon recently held in Chicago.

10 Feb 2010

Athena Cosmetics launches RevitaBrow to revitalize eyebrows

Beautifully shaped eyebrows frame the face, define the eyes and are regarded by makeup artists as an essential element to a finished look. Now, beautiful brows will be easier than ever to achieve with the help of RevitaBrow! RevitaBrow is the newest product to be introduced from Athena Cosmetics, Inc., maker of RevitaLash, the number one cosmetic eyelash conditioner.

10 Feb 2010

Role of online social network in emergency management

Online social networking sites could solve many problems plaguing information dissemination and communications when disaster strikes, according to a report from US researchers in a recent issue of the International Journal of Emergency Management.

10 Feb 2010

Clarient launches Clarient Insight Dx Pulmotype Test for lung cancer

Clarient, Inc., a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced the commercial launch of a new lung cancer test, Clarient Insight® Dx Pulmotype® Test, that helps physicians classify specific types of lung cancer to identify which therapies may be most effective.

10 Feb 2010

UH researchers create Walk n' Play iPhone application to keep track of physical activity

An iPhone application created by UH researchers is providing first-of-its-kind real-time statistics of physical activity around the world. Those annual rankings of America's fattest and fittest cities that use government statistics and a host of indirect indicators may soon have a little more muscle. The information being collected at the University of Houston provides objective data.

10 Feb 2010

Glide Pharma to utilize $4.3M funding for progressing octreotide programme into clinical development

Glide Pharma, a specialty pharmaceutical company focused on the needle-free administration of solid dose therapeutics and vaccines, today announced that it has completed an oversubscribed GBP2.7 million ($4.3 million) investment round. The fundraising was supported by a number of existing institutional and private investors, including Hygea VCT and Oxford Technology VCTs. The company has now completed four successful investment rounds, securing funding totalling approximately GBP10 million.

10 Feb 2010

Sartorius releases preliminary unaudited figures for fiscal 2009

Today Sartorius, a leading international process and laboratory technology provider, released its preliminary unaudited figures for fiscal 2009. In the reporting period, business in both Group divisions showed substantially divergent trajectories.

From Sartorius 10 Feb 2010

Continua Certified USB-enabled platform now available for building agent healthcare devices

Texas Instruments Incorporated and S3 Group, a connected healthcare technology solutions company, today announced the availability of the first Continua Certified™ USB-enabled platform for building agent healthcare devices.

10 Feb 2010

SMT Research and Development completes first two clinical cases using Shimon Embolic Filter

SMT Research and Development, Ltd., a privately held company, announced that it has completed its first two clinical cases using the Shimon Embolic Filter [SHEF] (TM). SMT R&D developed a novel technology for brain protection (Neuroprotection) from stroke complication hazards arising from invasive cardiology procedures and heart surgery.

10 Feb 2010

UnitedHealthcare launches OCA program for cancer patients

UnitedHealthcare, a UnitedHealth Group (NYSE: UNH) company, launched its Oncology Care Analysis (OCA) program. This patient-focused, integrated program uses a first-of-its-kind database that combines clinical and claims data to gauge the quality of cancer patient care based on approved treatment guidelines from the National Comprehensive Cancer Network (NCCN), an alliance of 21 leading cancer centers.

10 Feb 2010

Bulgaria deploys Gemalto' smart cards to secure access to personal health records for military personnel

Gemalto, the world leader in digital security, today announced that Bulgaria has started deploying its smart cards to secure access to personal health records for the country’s military personnel and their family.

10 Feb 2010

Neuroimaging technique could help in devising effective treatments for Alzheimer's disease

Scientists have determined that a new instrument known as PIB-PET is effective in detecting deposits of amyloid-beta protein plaques in the brains of living people, and that these deposits are predictive of who will develop Alzheimer's disease.

10 Feb 2010

Technology News and Research

Genzyme and Isis Pharmaceuticals: Phase 3 mipomersen study in heFH patients meets primary endpoint

Practice Fusion patient survey: Doctors are making use of EHR systems

STDUniversity.org launches interactive, personalized STD test recommendation

IndicatorEDG survey reveals Americans find less chance of achieving personal dreams

Alexza Pharmaceuticals announces development and commercialization collaboration with Biovail Laboratories International

Kinexus Bioinformatics announces the commercial release of Protein Kinase Microarray

Second-quarter fiscal 2010 results announced by Bioniche Life Sciences

Bombarding DNA nucleotides and mammalian meat with ‘femto-neutrons’ open new path to femtomedicine

MEDecision completes latest round of interoperability tests with other leading EHR vendors

Athena Cosmetics launches RevitaBrow to revitalize eyebrows

Role of online social network in emergency management

Clarient launches Clarient Insight Dx Pulmotype Test for lung cancer

UH researchers create Walk n' Play iPhone application to keep track of physical activity

Glide Pharma to utilize $4.3M funding for progressing octreotide programme into clinical development

Sartorius releases preliminary unaudited figures for fiscal 2009

Continua Certified USB-enabled platform now available for building agent healthcare devices

SMT Research and Development completes first two clinical cases using Shimon Embolic Filter

UnitedHealthcare launches OCA program for cancer patients

Bulgaria deploys Gemalto' smart cards to secure access to personal health records for military personnel

Neuroimaging technique could help in devising effective treatments for Alzheimer's disease

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News